MYNZ
Mainz Biomed B.V.
NASDAQ · Healthcare · Medical - Diagnostics & Research · DE
$3.59
+0.84%Margins
Gross margin
21.8%
EBITDA margin
-2860.2%
EBIT margin
-2796.0%
Net margin
-2520.9%
FCF margin
-2062.3%
-1394.7%
Return on equity
-358.8%
Return on assets
-694.8%
Return on invested capital
0.12x
Asset turnover
-$28.3M
Cash from operations
$0.61
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025